InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,631.64
(
0.64%
)
US TECH 100
19,034.40
(
0.56%
)
Dow Jones
41,452.58
(
0.87%
)
Brent Oil
71.43
(
-0.76%
)
Bitcoin
59,585.10
(
2.49%
)
Post# of 158400
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

sizzleweed

Send PM Follow Ignore
Followers 118
Posts 5283
Boards Moderated 1
Alias Born 02/11/2013

sizzleweed

Re: None

Monday, 03/25/2013 1:53:30 AM

Monday, March 25, 2013 1:53:30 AM

Post# of 158400
Take an aspirin and have a drink if you sold your shares cheap last week like so many of you did! IMHFO

Liftoff For Bio-Matrix Scientific Group (BMSN) As FDA Clears HemaXellerate And Awards It Coveted Orphan Drug Status Projects Biotech News Stock Review. Official News Imminent Now_Biotech News Stock Review Called It First!

Johnny is hearing from his very reliable sources that BMSN just hit the jackpot with their pipeline star drug HemaXellerate. Official news is imminent and both Johnny and I are a little surprised it has not yet been released but that is about to change. Check back for the latest updates from Biotech News Stock Review.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up